23 Oct 2020
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/sumitomo-dainippon-pharma-oncology-announces-first-patient-dosed-in-the-dubermatinib-arm-of-the-leukemia--lymphoma-societys-beat-aml-master-clinical-trial-in-patients-with-acute-myeloid-leukemia-301158414.html
18 Sep 2020
// BIOSPACE
https://www.biospace.com/article/releases/sumitomo-dainippon-pharma-oncology-presents-findings-from-phase-1-clinical-study-evaluating-investigational-agent-dubermatinib-in-patients-with-advanced-solid-tumors-at-esmo-2020-virtual-annual-congress/
LOOKING FOR A SUPPLIER?